The DOI matches its Crossref record; 47 of the 50 references it cites were found in a registry or an index.
The NALP3 inflammasome is involved in the innate immune response to amyloid-β
Open accessAbstract
The fibrillar peptide amyloid-beta (A beta) has a chief function in the pathogenesis of Alzheimer's disease. Interleukin 1 beta (IL-1 beta) is a key cytokine in the inflammatory response to A beta. Insoluble materials such as crystals activate the inflammasome formed by the cytoplasmic receptor NALP3, which results in the release of IL-1 beta. Here we identify the NALP3 inflammasome as a sensor of A beta in a process involving the phagocytosis of A beta and subsequent lysosomal damage and release of cathepsin B. Furthermore, the IL-1 beta pathway was essential for the microglial synthesis of proinflammatory and neurotoxic factors, and the inflammasome, caspase-1 and IL-1 beta were critical for the recruitment of microglia to exogenous A beta in the brain. Our findings suggest that activation of the NALP3 inflammasome is important for inflammation and tissue damage in Alzheimer's disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Based on the previous literature42,43,46, we reasoned that cathepsin B leaking from the destabilized lysosomes may mediate the NLRP3 inflammasome activation upon SHIP1 inhibition11.”
From INPP5D/SHIP1 regulates endo-lysosomal function and cargo-selective phagocytosis in human microglia (2025) · cites this paper as [43]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Fibrillar Aβ (fAβ), following phagocytosis by microglia, activates the NLRP3 inflammasome and leads to increases in secretion of IL-1β and IL-18.”
From Microglial function, INPP5D/SHIP1 signaling, and NLRP3 inflammasome activation: implications for Alzheimer’s disease (2023) · cites this paper as [78]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Sustained elevations of IL-1β have been postulated to play a key role in AD pathogenesis [6, 12–14].”
From 25-Hydroxycholesterol amplifies microglial IL-1β production in an apoE isoform-dependent manner (2020) · cites this paper as [13]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Halle et al. found that fibrillar Aβ can induce the secretion of IL-1β which depends on the presence of NLRP3.352,353”
From Role of neuroinflammation in neurodegeneration development (2023) · cites this paper as [352]
The cited source says what the claim attributes to it.
In the citing paper
“lysosomal cathepsins, such as cathepsin B, can induce NLRP3 inflammasome activation upon leaking into the cytosol following lysosomal membrane permeabilization (LMP)42,43”
From INPP5D/SHIP1 regulates endo-lysosomal function and cargo-selective phagocytosis in human microglia (2025) · cites this paper as [43]
The cited source says what the claim attributes to it.
In the citing paper
“fAβ phagocytosis results in lysosomal dysfunction and release of lysosomal contents into the cytoplasm, including the lysosomal protease cathepsin B, which is a mediator of inflammasome activation induced by Aβ [78].”
From Microglial function, INPP5D/SHIP1 signaling, and NLRP3 inflammasome activation: implications for Alzheimer’s disease (2023) · cites this paper as [78]
The cited source says what the claim attributes to it.
In the citing paper
“In line with these findings, another study showed that aggregated tau seeds activated the NLRP3 inflammasome in primary mouse microglia by inducing lysosomal destabilization and release of the lysosomal protease cathepsin B, similar to fAβ [78, 82].”
From Microglial function, INPP5D/SHIP1 signaling, and NLRP3 inflammasome activation: implications for Alzheimer’s disease (2023) · cites this paper as [78]
The cited source says what the claim attributes to it.
In the citing paper
“In parallel, reduction of SHIP1 activity is poised to disinhibit signaling pathways that are involved in the phagocytosis of Aβ, which is a required step for Aβ-induced activation of the NLRP3 inflammasome [78].”
From Microglial function, INPP5D/SHIP1 signaling, and NLRP3 inflammasome activation: implications for Alzheimer’s disease (2023) · cites this paper as [78]
In the citing paper
“Notably, Aβ also can activate NF-κB signaling and the NLRP3-ASC inflammasome [426, 427], suggesting that Aβ and tau share common mechanisms in microglia activation.”
From Molecular and cellular mechanisms underlying the pathogenesis of Alzheimer’s disease (2020) · cites this paper as [426]
In the citing paper
“Following phagocytosis by microglia, Aβ activates the NLRP3 inflammasome leading to caspase-1 activation and IL-1β maturation and release (Halle et al., 2008).”
From Alzheimer Disease: An Update on Pathobiology and Treatment Strategies (2019) · cites this paper as Halle et al., 2008
In the citing paper
“Fibrillar Aβ amyloids can induce the secretion of IL-1β from microglia, via the NLRP3 inflammasome (228, 249).”
From The gut-brain axis: how microbiota and host inflammasome influence brain physiology and pathology (2020) · cites this paper as [228]
In the citing paper
“Importantly, researchers also found that ASC-, caspase-1-, IL-1 receptor-, and MyD88-deficient mice had less recruitment of microglia and mononuclear phagocytes to Aβ in the brain as compared to the wild type control after the injection of Aβ into the striatum (228).”
From The gut-brain axis: how microbiota and host inflammasome influence brain physiology and pathology (2020) · cites this paper as [228]
In the citing paper
“NLRP3 has been shown to respond to sterile stimuli, including asbestos, silica, MSU and CPPD crystals55, cholesterol crystals and β-amyloid fibrils56.”
From Sterile inflammation: sensing and reacting to damage (2010) · cites this paper as [56]
In the citing paper
“Furthermore, there is only partial inhibition of the neutrophil infiltration and IL-1β production associated with sterile inflammation in response to cholesterol crystals44,56,59,67.”
From Sterile inflammation: sensing and reacting to damage (2010) · cites this paper as [56]
In the citing paper
“However, cathepsin b-deficient macrophages have no impairment in IL-1β production in response to certain NLRP3 agonists, including LPS plus ATP, or MSU crystals, despite the impairment in their response to silica44,56,59,67.”
From Sterile inflammation: sensing and reacting to damage (2010) · cites this paper as [56]
In the citing paper
“evidence to support this are the observations that artificial lysosomal rupture alone can activate NLRP3 and that pharmacological inhibition or genetic depletion of cathepsin b results in inhibition of caspase 1 activation, although this inhibition was only partial44,56,59.”
From Sterile inflammation: sensing and reacting to damage (2010) · cites this paper as [56]
In the citing paper
“In support of this, direct treatment of ATP on primed microglia is sufficient for maturation and release of IL-1β in vitro (Halle et al, 2008) and does so via the P2X 7 receptor (Colomar et al, 2003) expressed on microglia (Monif et al, 2009).”
From Repeated Social Defeat, Neuroinflammation, and Behavior: Monocytes Carry the Signal (2017) · cites this paper as Halle et al, 2008
In the citing paper
“In particular, microglial NLRP3 has been shown to be a major driver of amyloid beta and tau toxicity in AD, suggesting its activation has important implications for disease progression (Halle et al, 2008; Venegas et al, 2017; Ising et al, 2019).”
From Mechanisms of DNA damage-mediated neurotoxicity in neurodegenerative disease (2022) · cites this paper as Halle et al, 2008
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Gout-associated uric acid crystals activate the NALP3 inflammasome
Martinon, F., Pétrilli, V., Mayor, A., Tardivel, A., & Tschopp, J. (2006) · Nature · doi:10.1038/nature04516 · Cited by 5,326
Immunization with amyloid-β attenuates Alzheimer-disease-like pathology in the PDAPP mouse
Schenk, D., Barbour, R., Dunn, W., Gordon, G., Grajeda, H., Guido, T., Hu, K., Huang, J., Johnson-Wood, K., Khan, K., et al. (1999) · Nature · doi:10.1038/22124 · Cited by 3,160
Cryopyrin activates the inflammasome in response to toxins and ATP
Mariathasan, S., Weiss, D. S., Newton, K., McBride, J., O'Rourke, K., Roose-Girma, M., Lee, W. P., Weinrauch, Y., Monack, D. M., & Dixit, V. M. (2006) · Nature · doi:10.1038/nature04515 · Cited by 3,080
Innate Immune Activation Through Nalp3 Inflammasome Sensing of Asbestos and Silica
Dostert, C., Pétrilli, V., Van Bruggen, R., Steele, C., Mossman, B. T., & Tschopp, J. (2008) · Science · doi:10.1126/science.1156995 · Cited by 2,658
Germline Transmission and Tissue-Specific Expression of Transgenes Delivered by Lentiviral Vectors
Lois, C., Hong, E. J., Pease, S., Brown, E. J., & Baltimore, D. (2002) · Science · doi:10.1126/science.1067081 · Cited by 1,992
Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease.
Griffin, W. S., Stanley, L. C., Ling, C., White, L., MacLeod, V, Perrot, L. J., White, C. L., & Araoz, C. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.19.7611 · Cited by 1,777
Agostini, L., Martinon, F., Burns, K., McDermott, M. F., Hawkins, P. N., & Tschopp, J. (2004) · Immunity · doi:10.1016/s1074-7613(04)00046-9 · Cited by 1,768
Altered Cytokine Export and Apoptosis in Mice Deficient in Interleukin-1β Converting Enzyme
Kuida, K., Lippke, J. A., Ku, G., Harding, M. W., Livingston, D. J., Su, M. S. S., & Flavell, R. A. (1995) · Science · doi:10.1126/science.7535475 · Cited by 1,631
A subset of NSAIDs lower amyloidogenic Aβ42 independently of cyclooxygenase activity
Weggen, S., Eriksen, J. L., Das, P., Sagi, S. A., Wang, R., Pietrzik, C. U., Findlay, K. A., Smith, T. E., Murphy, M. P., Bulter, T., et al. (2001) · Nature · doi:10.1038/35102591 · Cited by 1,388
Simard, A. R., Soulet, D., Gowing, G., Julien, J.-P., & Rivest, S. (2006) · Neuron · doi:10.1016/j.neuron.2006.01.022 · Cited by 1,265
Flagged first, then by citations
3 of the 50 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 801–900 of 1,015
Immune Activation in Alzheimer Disease
Mary, A., Mancuso, R., & Heneka, M. T. (2024) · Annual Review of Immunology · doi:10.1146/annurev-immunol-101921-035222 · Cited by 82
Zhao, Y., Guo, Q., Zhu, Q., Tan, R. X., Bai, D., Bu, X., Lin, B., Zhao, K., Pan, C., Chen, H., et al. (2019) · Mucosal Immunology · doi:10.1038/s41385-019-0177-x · Cited by 74
Efficacy and mechanism of cGAMP to suppress Alzheimer’s disease by elevating TREM2
Xu, Q., Xu, W., Cheng, H., Yuan, H., & Tan, X. (2019) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2019.07.004 · Cited by 75
Age-Related Hearing Loss: The Link between Inflammaging, Immunosenescence, and Gut Dysbiosis
Kociszewska, D., & Vlajkovic, S. M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23137348 · Cited by 82
Sharma, B., Satija, G., Madan, A., Garg, M., Alam, M. M., Shaquiquzzaman, M., Khanna, S., Tiwari, P., Parvez, S., Iqubal, A., et al. (2022) · Inflammation · doi:10.1007/s10753-022-01730-0 · Cited by 77
Targeting NLRP3 inflammasome for neurodegenerative disorders
Yao, J., Wang, Z., Song, W., & Zhang, Y. (2023) · Molecular Psychiatry · doi:10.1038/s41380-023-02239-0 · Cited by 81
Gupta, R., Ghosh, S., Monks, B. G., DeOliveira, R. B., Tzeng, T.-C. J., Kalantari, P., Nandy, A., Bhattacharjee, B., Chan, J., Ferreira, F., et al. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.c114.548982 · Cited by 75
Self-citationThe rhapsody of NLRPs: master players of inflammation … and a lot more
Zambetti, L. P., Laudisi, F., Licandro, G., Ricciardi‐Castagnoli, P., & Mortellaro, A. (2012) · Immunologic Research · doi:10.1007/s12026-012-8272-z · Cited by 75
Westwell-Roper, C. Y., Chehroudi, C., Denroche, H. C., Courtade, J. A., Ehses, J. A., & Verchere, C. B. (2014) · Diabetologia · doi:10.1007/s00125-014-3447-x · Cited by 75
Control of innate and adaptive immunity by the inflammasome
Çıracı, C., Janczy, J. R., Sutterwala, F. S., & Cassel, S. L. (2012) · Microbes and Infection · doi:10.1016/j.micinf.2012.07.007 · Cited by 75
Nagpal, K., Plantinga, T. S., Wong, J., Monks, B. G., Gay, N. J., Netea, M. G., Fitzgerald, K. A., & Golenbock, D. T. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.014886 · Cited by 75
Self-citationKaarniranta, K., & Salminen, A. (2008) · Journal of Molecular Medicine · doi:10.1007/s00109-008-0418-z · Cited by 77
Regulation of interleukin-1 in acute brain injury
Brough, D., Tyrrell, P. J., & Allan, S. M. (2011) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2011.06.002 · Cited by 78
IL-33 and its decoy sST2 in patients with Alzheimer’s disease and mild cognitive impairment
Saresella, M., Marventano, I., Piancone, F., La Rosa, F., Galimberti, D., Fenoglio, C., Scarpini, E., & Clerici, M. (2020) · Journal of Neuroinflammation · doi:10.1186/s12974-020-01806-4 · Cited by 75
Piippo, N., Korhonen, E., Hytti, M., Kinnunen, K., Kaarniranta, K., & Kauppinen, A. (2018) · Cellular Physiology and Biochemistry · doi:10.1159/000492886 · Cited by 74
Chen, H., Lin, H. P., Xie, S., Huang, B., Qian, Y., Chen, K., Niu, Y., Shen, H., Cai, J., Li, P., et al. (2018) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2018.12.019 · Cited by 75
Leng, W., Wu, M., Pan, H., Lei, X., Chen, L., Wu, Q., Ouyang, X., & Liang, Z. (2019) · Annals of Translational Medicine · doi:10.21037/atm.2019.09.03 · Cited by 75
Danger-Sensing/Patten Recognition Receptors and Neuroinflammation in Alzheimer’s Disease
Chiarini, A., Armato, U., Hu, P., & Prà, I. D. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21239036 · Cited by 77
Distinct Features of Brain-Resident Macrophages: Microglia and Non-Parenchymal Brain Macrophages
Lee, E., Eo, J.-C., Lee, C., & Yu, J. (2021) · Molecules and Cells · doi:10.14348/molcells.2021.0060 · Cited by 83
Neuroinflammatory Signaling in the Pathogenesis of Alzheimer’s Disease
Uddin, M. S., Kabir, M. T., Jalouli, M., Rahman, M. A., Jeandet, P., Behl, T., Alexiou, A. T., Albadrani, G. M., Abdel‐Daim, M. M., Perveen, A., et al. (2021) · Current Neuropharmacology · doi:10.2174/1570159x19666210826130210 · Cited by 76
Parodi‐Rullán, R. M., Javadov, S. A., & Fossati, S. (2021) · Cells · doi:10.3390/cells10112903 · Cited by 75
iGLuc: a luciferase-based inflammasome and protease activity reporter
Bartok, E., Bauernfeind, F. G., Khaminets, M. G., Jakobs, C., Monks, B. G., Fitzgerald, K. A., Latz, E., & Hornung, V. (2013) · Nature Methods · doi:10.1038/nmeth.2327 · Cited by 73
Self-citationA Role for Stefin B (Cystatin B) in Inflammation and Endotoxemia
Maher, K., Kokelj, B. J., Butinar, M., Mikhaylov, G., Manček‐Keber, M., Stoka, V., Vasiljeva, O. S., Turk, B., Grigoryev, S. A., & Kopitar‐Jerala, N. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.609396 · Cited by 73
P2X7 as a scavenger receptor for innate phagocytosis in the brain
Gu, B. J., & Wiley, J. S. (2018) · British Journal of Pharmacology · doi:10.1111/bph.14470 · Cited by 75
Mezzasoma, L., Antognelli, C., & Talesa, V. N. (2015) · Immunologic Research · doi:10.1007/s12026-015-8751-0 · Cited by 74
NLRP7: From inflammasome regulation to human disease
Carrière, J., Dorfleutner, A., & Stehlik, C. (2021) · Immunology · doi:10.1111/imm.13372 · Cited by 78
Targeting Inflammasomes to Treat Neurological Diseases
Lünemann, J. D., Malhotra, S., Shinohara, M. L., Montalbán, X., & Comabella, M. (2021) · Annals of Neurology · doi:10.1002/ana.26158 · Cited by 73
Pyroptosis in development, inflammation and disease
Pan, Y., Cai, W., Huang, J., Cheng, A., Wang, M., Yin, Z., & Jia, R. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.991044 · Cited by 74
The role of dopamine in NLRP3 inflammasome inhibition: Implications for neurodegenerative diseases
Possemato, E., Barbera, L. L., Nobili, A., Krashia, P., & D’Amelio, M. (2023) · Ageing Research Reviews · doi:10.1016/j.arr.2023.101907 · Cited by 76
Al‐kuraishy, H. M., Jabir, M. S., Albuhadily, A. K., Al-Gareeb, A. I., & Rafeeq, M. F. (2023) · Ageing Research Reviews · doi:10.1016/j.arr.2023.102084 · Cited by 75
The impact of neuroinflammation on neuronal integrity
Tastan, B., & Heneka, M. T. (2024) · Immunological Reviews · doi:10.1111/imr.13419 · Cited by 81
Satoh, T. K., Kambe, N., & Matsue, H. (2013) · Cell Death and Disease · doi:10.1038/cddis.2013.169 · Cited by 75
Expression of IL-1β in rhesus EAE and MS lesions is mainly induced in the CNS itself
Burm, S. M., Peferoen, L. A. N., Zuiderwijk-Sick, E. A., Haanstra, K. G., Hart, B. A. ‘., van der Valk, P., Amor, S., Bauer, J., & Bajramovic, J. J. (2016) · Journal of Neuroinflammation · doi:10.1186/s12974-016-0605-8 · Cited by 73
The NLRP3 inflammasome modulates tau pathology and neurodegeneration in a tauopathy model
Stancu, I. C., Lodder, C., Botella Lucena, P., Vanherle, S., Gutiérrez de Ravé, M., Terwel, D., Bottelbergs, A., & Dewachter, I. (2022) · Glia · doi:10.1002/glia.24160 · Cited by 72
Innate Immunity in Alzheimer’s Disease: A Complex Affair
Guillot‐Sestier, M., & Town, T. (2013) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527311312050008 · Cited by 72
Wang, X., Sun, B., Liu, S., & Xia, T. (2016) · NanoImpact · doi:10.1016/j.impact.2016.08.002 · Cited by 72
Lee, E. Y., Srinivasan, Y., de Anda, J., Nicastro, L. K., Tükel, Ç., & Wong, G. C. L. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01629 · Cited by 70
Chen, K.-P., Hua, K., Tsai, F.-T., Lin, T.-Y., Cheng, C., Yang, D., Hsu, H.-T., & Ju, T. (2022) · Journal of Neuroinflammation · doi:10.1186/s12974-022-02419-9 · Cited by 78
Pereira, A. C., Pascale, J. D., Resende, R., Cardoso, S., Ferreira, I., Neves, B. M., Carrascal, M. A., Zuzarte, M., Madeira, N. G. G. F., Morais, S., et al. (2022) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-022-04211-7 · Cited by 81
RAGE-TXNIP axis drives inflammation in Alzheimer’s by targeting Aβ to mitochondria in microglia
Sbai, O., Djelloul, M., Auletta, A., Ieraci, A., Vascotto, C., & Perrone, L. (2022) · Cell Death & Disease · doi:10.1038/s41419-022-04758-0 · Cited by 72
NLRP3 Inflammasome Activation by Paracoccidioides brasiliensis
Tavares, A. H., Magalhães, K. G., Almeida, R. D. N., Corrêa, R., Bürgel, P. H., & Bocca, A. L. (2013) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0002595 · Cited by 71
NLRP3 is Required for Complement-Mediated Caspase-1 and IL-1beta Activation in ICH
Yao, S., Cao, F., Chen, J., Chen, W., Fan, R., Li, G., Zeng, Y.-C., Song, J., Xia, X., Han, C., et al. (2016) · Journal of Molecular Neuroscience · doi:10.1007/s12031-016-0874-9 · Cited by 73
Complement C5a potentiates uric acid crystal‐induced IL‐1β production
An, L., Mehta, P., Xu, L., Turman, S., Reimer, T., Naiman, B. M., Connor, J. R., Sanjuán, M. A. F., Kolbeck, R., & Fung, M. S. C. (2014) · European Journal of Immunology · doi:10.1002/eji.201444560 · Cited by 71
Targeting NLRP3-Mediated Neuroinflammation in Alzheimer’s Disease Treatment
Barczuk, J., Siwecka, N., Lusa, W., Rozpędek‐Kamińska, W., Kucharska, E., & Majsterek, I. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23168979 · Cited by 76
RBP–RNA interactions in the control of autoimmunity and autoinflammation
Liu, J., & Cao, X. (2023) · Cell Research · doi:10.1038/s41422-022-00752-5 · Cited by 74
NLRP3 inflammasome and its role in autoimmune diseases: A promising therapeutic target
Ren, W., Sun, Y., Zhao, L., & Shi, X. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.116679 · Cited by 80
Roles of Cytokines in Alzheimer’s Disease
Chen, Z., Balachandran, Y. L., Chong, W. P., & Chan, K. W. Y. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25115803 · Cited by 75
Yoo, J., Lee, J., Ahn, B., Han, J., & Lim, M. H. (2025) · Chemical Science · doi:10.1039/d4sc06762b · Cited by 78
Gallego, C., Golenbock, D. T., Gómez, M. A., & Saravia, N. G. (2011) · Infection and Immunity · doi:10.1128/iai.01388-10 · Cited by 71
Self-citationGordon, E. M., Yao, X., Xu, H., Karkowsky, W., Kaler, M. M., Kalchiem‐Dekel, O., Barochia, A. V., Gao, M., Keeran, K. J., Jeffries, K. R., et al. (2019) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2019.02.027 · Cited by 70
Pattern recognition receptor‐mediated inflammation in diabetic vascular complications
Wang, X., Antony, V., Wang, Y., Wu, G., & Liang, G. (2020) · Medicinal Research Reviews · doi:10.1002/med.21711 · Cited by 73
Schweneker, K., Gorka, O., Schweneker, M., Poeck, H., Tschopp, J., Peschel, C., Ruland, J., & Groß, O. (2012) · Immunobiology · doi:10.1016/j.imbio.2012.07.029 · Cited by 70
Sanberg, P. R., Eve, D. J., Willing, A. E., Garbuzova-Davis, S. N., Tan, J., Sanberg, C. D., Allickson, J. G., Cruz, L. E. G., & Borlongan, C. V. (2010) · Cell Transplantation · doi:10.3727/096368910x532855 · Cited by 72
Abdelaziz, D. H., Khalil, H., Cormet‐Boyaka, E., & Amer, A. O. (2015) · Immunological Reviews · doi:10.1111/imr.12288 · Cited by 68
α1-antitrypsin mitigates NLRP3-inflammasome activation in amyloid β1–42-stimulated murine astrocytes
Ebrahimi, T., Rust, M. I., Kaiser, S., Slowik, A., Beyer, C., Koczulla, A. R., Schulz, J. B., Habib, P., & Bach, J. (2018) · Journal of Neuroinflammation · doi:10.1186/s12974-018-1319-x · Cited by 72
Microglia Receptors in Animal Models of Traumatic Brain Injury
Younger, D., Murugan, M., Rao, K. V. R., Wu, L., & Chandra, N. (2018) · Molecular Neurobiology · doi:10.1007/s12035-018-1428-7 · Cited by 69
The strategies of targeting the NLRP3 inflammasome to treat inflammatory diseases
Jiang, H., Gong, T., & Zhou, R. (2019) · Advances in immunology · doi:10.1016/bs.ai.2019.11.003 · Cited by 71
Ribarič, S. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23063245 · Cited by 77
The VCAM1–ApoE pathway directs microglial chemotaxis and alleviates Alzheimer’s disease pathology
Lau, S.-F., Wu, W., Wong, H. Y., Ouyang, L., Qiao, Y., Xu, J., Lau, J. H.-Y., Wong, C., Jiang, Y., Holtzman, D. M., et al. (2023) · Nature Aging · doi:10.1038/s43587-023-00491-1 · Cited by 70
Kapétanovic, R., Bokil, N. J., & Sweet, M. J. (2015) · Ageing Research Reviews · doi:10.1016/j.arr.2015.02.005 · Cited by 70
Lichtnekert, J., Kulkarni, O. P., Mulay, S. R., Rupanagudi, K. V., Ryu, M., Allam, R., Vielhauer, V., Muruve, D. A., Lindenmeyer, M. T., Cohen, C. D., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0026778 · Cited by 71
Amyloid Fibrils Composed of Hexameric Peptides Attenuate Neuroinflammation
Kurnellas, M., Adams, C. M., Sobel, R. A., Steinman, L., & Rothbard, J. B. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3005681 · Cited by 72
Complement-mediated ‘bystander’ damage initiates host NLRP3 inflammasome activation
Suresh, R., Chandrasekaran, P., Sutterwala, F. S., & Mosser, D. M. (2016) · Journal of Cell Science · doi:10.1242/jcs.179291 · Cited by 68
Nicolson, G. L., & Ash, M. E. (2017) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2017.04.013 · Cited by 75
Pitenis, A. A., Urueña, J. M., Hart, S. M., O’Bryan, C. S., Marshall, S. L., Levings, P. P., Angelini, T. E., & Sawyer, W. G. (2018) · Tribology Letters · doi:10.1007/s11249-018-1029-7 · Cited by 69
Inflammation: Bridging Age, Menopause and APOEε4 Genotype to Alzheimer’s Disease
Mishra, A., & Brinton, R. D. (2018) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2018.00312 · Cited by 71
SUMO1 SUMOylates and SENP3 deSUMOylates NLRP3 to orchestrate the inflammasome activation
Shao, L., Liu, Y., Wang, W., Li, A., Wan, P., Liu, W., Shereen, M. A., Liu, F., Zhang, W., Tan, Q., et al. (2018) · The FASEB Journal · doi:10.1096/fj.201901653r · Cited by 68
Macrophage HIF-2α suppresses NLRP3 inflammasome activation and alleviates insulin resistance
Li, X., Zhang, X., Xia, J., Zhang, L., Chen, B., Lian, G., Yun, C., Yang, J., Yan, Y., Wang, P., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.109607 · Cited by 71
Ha, S.-D., Ham, B., Mogridge, J., Säftig, P., Lin, S., & Kim, S. O. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.065813 · Cited by 71
Francisella tularensis Reveals a Disparity between Human and Mouse NLRP3 Inflammasome Activation
Atianand, M., Duffy, E. B., Shah, A., Kar, S., Malik, M., & Harton, J. A. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.244079 · Cited by 73
Hoyle, C., Rivers‐Auty, J., Lemarchand, E., Vranic, S., Wang, E., Buggio, M., Rothwell, N. J., Allan, S. M., Kostarelos, K., & Brough, D. (2018) · ACS Nano · doi:10.1021/acsnano.8b03642 · Cited by 68
The role of inflammatory processes in Alzheimer’s disease
Broussard, G. J., Mytar, J. O., Li, R., & Klapstein, G. J. (2012) · Inflammopharmacology · doi:10.1007/s10787-012-0130-z · Cited by 71
Dysregulation of Inflammasome Priming and Activation by MicroRNAs in Human Immune-Mediated Diseases
Boxberger, N., Hecker, M., & Zettl, U. K. (2019) · The Journal of Immunology · doi:10.4049/jimmunol.1801416 · Cited by 71
Hoyle, C., Green, J., Allan, S. M., Brough, D., & Lemarchand, E. (2022) · Immunology · doi:10.1111/imm.13454 · Cited by 69
Monogenic autoinflammatory diseases: new insights into clinical aspects and pathogenesis
Henderson, C., & Goldbach‐Mansky, R. T. (2010) · Current Opinion in Rheumatology · doi:10.1097/bor.0b013e32833ceff4 · Cited by 69
Decline in cellular clearance systems induces inflammasome signaling in human ARPE-19 cells
Piippo, N., Korkmaz, A., Hytti, M., Kinnunen, K., Salminen, A., Atalay, M., Kaarniranta, K., & Kauppinen, A. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2014.09.015 · Cited by 69
Inflammasome-Dependent Cytokines at the Crossroads of Health and Autoinflammatory DiseasePreprint
Gorp, H. V., Opdenbosch, N. V., & Lamkanfi, M. (2017) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a028563 · Cited by 69
Current perspectives on the link between neuroinflammation and neurogenesis
Wang, B. Z., & Jin, K. (2014) · Metabolic Brain Disease · doi:10.1007/s11011-014-9523-6 · Cited by 68
McManus, R. M., Komes, M. P., Griep, A., Santarelli, F., Schwartz, S., Perea, J. R., Schlachetzki, J. C. M., Bouvier, D. S., Khalil, M., Lauterbach, M., et al. (2025) · Immunity · doi:10.1016/j.immuni.2025.01.007 · Cited by 81
Self-citationThe Biphasic Role of Microglia in Alzheimer's Disease
Mizuno, T. (2012) · International Journal of Alzheimer s Disease · doi:10.1155/2012/737846 · Cited by 73
Averette, K. M., Pratt, M. R., Yang, Y., Bassilian, S., Whitelegge, J. P., Loo, J. A., Muir, T. W., & Bradley, K. A. (2009) · PLoS ONE · doi:10.1371/journal.pone.0007913 · Cited by 66
Maher, J. J. (2009) · Journal of Clinical Investigation · doi:10.1172/jci38178 · Cited by 67
Emerging Significance of NLRs in Inflammatory Bowel Disease
Davis, B. K., Philipson, C. W., Hontecillas, R., Eden, K. B., Bassaganya-Riera, J., & Allen, I. C. (2014) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000000151 · Cited by 69
Nagarajan, U. M., Sikes, J. D., Yeruva, L., & Prantner, D. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1103461 · Cited by 68
NLRP3 inflammasome inhibitor INF39 attenuated NLRP3 assembly in macrophages
Shi, Y., Lv, Q., Zheng, M., Sun, H., & Shi, F. (2021) · International Immunopharmacology · doi:10.1016/j.intimp.2020.107358 · Cited by 67
The Role of Melatonin on NLRP3 Inflammasome Activation in Diseases
Arioz, B. I., Tarakcioglu, E., Olcum, M., & Genç, Ş. (2021) · Antioxidants · doi:10.3390/antiox10071020 · Cited by 67
Madhu, L. N., Kodali, M., Upadhya, R., Rao, S., Somayaji, Y., Attaluri, S., Shuai, B., Kirmani, M., Gupta, S., Maness, N., et al. (2024) · Journal of Extracellular Vesicles · doi:10.1002/jev2.12519 · Cited by 69
Microglia in Alzheimer’s Disease
Li, Y., Tan, M., Jiang, T., & Tan, L. (2014) · BioMed Research International · doi:10.1155/2014/437483 · Cited by 69
Role of Genetic Alterations in the NLRP3 and CARD8 Genes in Health and Disease
Paramel, G. V., Sirsjö, A., & Fransén, K. (2015) · Mediators of Inflammation · doi:10.1155/2015/846782 · Cited by 66
Role of the Inflammasome in Myocardial Infarction
Takahashi, M. (2011) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2012.02.002 · Cited by 66
Bezbradica, J. S., Coll, R. C., & Schroder, K. (2016) · Cellular and Molecular Immunology · doi:10.1038/cmi.2016.11 · Cited by 67
Inflammasome Involvement in Alzheimer’s Disease
Olsen, I., & Singhrao, S. K. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-160197 · Cited by 66
Wang, H., Zhang, T., Huang, J., Xiang, J., Chen, J., Fu, J., & Zhao, Y. (2017) · Cellular Physiology and Biochemistry · doi:10.1159/000481753 · Cited by 66
Hong, Y., Liu, Y., Yu, D., Wang, M., & Yan-ning, H. (2019) · International Immunopharmacology · doi:10.1016/j.intimp.2019.05.054 · Cited by 67
Protection of MCC950 against Alzheimer's disease via inhibiting neuronal pyroptosis in SAMP8 mice
Li, J., Zhuang, L., Luo, X., Liang, J., Sun, E., & He, Y. (2020) · Experimental Brain Research · doi:10.1007/s00221-020-05916-6 · Cited by 68
Microglia: Friend and foe in tauopathy
Odfalk, K. F., Bieniek, K. F., & Hopp, S. C. (2022) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2022.102306 · Cited by 60
UNC93B1 Mediates Host Resistance to Infection with Toxoplasma gondii
Melo, M. B., Kasperkovitz, P. V., Cerny, A., Könen‐Waisman, S., Kurt‐Jones, E. A., Lien, E., Beutler, B., Howard, J. C., Golenbock, D. T., & Gazzinelli, R. T. (2010) · PLoS Pathogens · doi:10.1371/journal.ppat.1001071 · Cited by 65
Self-citationThe role of NLRs and TLRs in the activation of the inflammasome
Netea, M. G., van de Veerdonk, F. L., Kullberg, B. J., van der Meer, J. W. M., & Joosten, L. A. B. (2008) · Expert Opinion on Biological Therapy · doi:10.1517/14712590802494212 · Cited by 65
Neuroinflammation and Copper in Alzheimer’s Disease
Choo, X. Y., Alukaidey, L., White, A. R., & Grubman, A. (2013) · International Journal of Alzheimer s Disease · doi:10.1155/2013/145345 · Cited by 70
Tumor suppressor death-associated protein kinase is required for full IL-1β production
Chuang, Y.-T., Lin, Y., Lin, K., Chou, T.-F., Kuo, W., Yang, K., Wu, P., Chen, R., Kimchi, A., & Lai, M. (2010) · Blood · doi:10.1182/blood-2010-08-303115 · Cited by 65
Metadata
- Authors
- Halle, A., Hornung, V., Petzold, G. C., Stewart, C. R., Monks, B. G., Reinheckel, T., Fitzgerald, K. A., Latz, E., Moore, K. J., & Golenbock, D. T.
- Affiliations
- University of Massachusetts Chan Medical School (US)
- Harvard University (US)
- University of Freiburg (DE)
- Corresponding author
- Golenbock, Douglas T
- ORCID
- Venue
- Nature Immunology
- Published
- 2008-07-11
- Volume
- 9
- Issue
- 8
- Pages
- 857-865
- ISSN
- 1529-2908 (ISSN-L)
- 1529-2916
- PMC
- PMC3101478
- OpenAlex
- W2119098586
- Cited by
- 2,441
- References
- 50
- Citations by year
- 2026: 92 · 2025: 124 · 2024: 143 · 2023: 165 · 2022: 191 · 2021: 188 · 2020: 169 · 2019: 151 · 2018: 136 · 2017: 139 · 2016: 138 · 2015: 146 · 2014: 149 · 2013: 153 · 2012: 98
- FWCI
- 35.20
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Immunology (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- eScholarship@UMassChan (submittedVersion)
- MPG.PuRe (Max Planck Society) (submittedVersion)
- Funders
- National Institute on Aging (R01AG020255, AG20255)
- National Institute of General Medical Sciences (R37GM054060, R01GM054060, GM 54060)
- National Institute of Allergy and Infectious Diseases (AI065483, R01AI065483)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Inflammasome and immune disorders
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Keywords
- NLRP3 inflammasome, amyloid-beta, Alzheimer's disease, innate immunity, IL-1β, caspase-1, microglia, phagocytosis, lysosomal damage, cathepsin B, neuroinflammation, neurotoxicity
- MeSH terms
- NLR Family, Pyrin Domain-Containing 3 Protein, Alzheimer Disease, Carrier Proteins, Immunity, Innate, Inflammation, Amyloid beta-Peptides, Inflammation Mediators
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
